From: The association between oxidized low-density lipoprotein antibodies and hematological diseases
Parameters in the regression model | Dependent Var oxLDL-IgM | Dependent Var oxLDL-IgG | ||||
---|---|---|---|---|---|---|
B | Wald | P | B | Wald | P | |
Constant | 13.281 | 7.294 | 0.007 | 69.359 | 52.451 | <0.001 |
Gender (M/F) | 0.054 | 0.003 | 0.956 | 5.797 | 8.663 | 0.003 |
cases with non lymphatic leukemia | 5.418 | 7.315 | 0.007 | −37.985 | 106.186 | <0.001 |
cases with lymphatic leukemia | 8.340 | 11.736 | 0.001 | −47.171 | 110.637 | <0.001 |
cases with Hemolytic anemia | 11.541 | 18.090 | <0.001 | −44.355 | 71.523 | <0.001 |
cases with immunothrombocytopenia | 6.469 | 9.687 | 0.002 | −26.003 | 39.866 | <0.001 |
cases with multiple myeloma | 8.833 | 15.391 | <0.001 | −16.732 | 13.011 | <0.001 |
cases with non Kochkin’s | 9.716 | 22.301 | <0.001 | −32.233 | 63.987 | <0.001 |
cases with myelodysplastic syndrome | 7.196 | 7.659 | 0.006 | −57.709 | 161.408 | <0.001 |
patients with primary hypertension | 1.692 | 0.697 | 0.404 | 4.992 | 1.440 | 0.230 |
healthy normal personsa | 0.0 | . | . | 0.0 | . | . |